Immunization with L. sigmodontis microfilariae reduces peripheral microfilaraemia after challenge infection by inhibition of filarial embryogenesis

PLoS Neglected Tropical Diseases

Volumn 6, Issue 3, 2012, Pages

  Ziewer, Sebastian ^a   Hübner, Marc P ^a   Dubben, Bettina ^a   Hoffmann, Wolfgang H ^b   Bain, Odile ^c   Martin, Coralie ^c   Hoerauf, Achim ^a   Specht, Sabine ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IVERMECTIN; ALUMINUM SULFATE; IMMUNOLOGICAL ADJUVANT; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; LITOMOSOIDES SIGMODONTIS; MALE; MICROFILARIA (NEMATODE LARVA); MICROFILARIASIS; MOUSE; NONHUMAN; PLEURA CAVITY; VACCINATION; WORM INFECTION; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; FILARIASIS; FILARIOIDEA; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; PARASITE LOAD; PARASITEMIA;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FILARIASIS; FILARIOIDEA; HUMANS; MICE; MICE, INBRED BALB C; PARASITE LOAD; PARASITEMIA; VACCINATION; VACCINES;

EID: 84859183387     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001558     Document Type: Article

References (62)

1. Taylor MJ, Hoerauf A, Bockarie M, (2010) Lymphatic filariasis and onchocerciasis. Lancet 376: 1175-1185.
2. Hoerauf A, Pfarr K, Mand S, Debrah AY, Specht S, (2011) Filariasis in Africa-treatment challenges and prospects. Clin Microbiol Infect 17: 977-985.
3. WHO (2011) Global Programme to Eliminate Lymphatic Filariasis: progress report on mass drug administration. Wkly Epidemiol Rec 86: 377-387.
4. WHO (2010) African Programme for Onchocerciasis Control - report of the sixth meeting of national task forces, October 2009. Wkly Epidemiol Rec 85: 21-28.
5. Hoerauf A, (2008) Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis. CurrOpinInfectDis 21: 673-681.
6. Hoerauf A, Mand S, Adjei O, Fleischer B, Buttner DW, (2001) Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 357: 1415-1416.
7. Hoerauf A, Volkmann L, Hamelmann C, Adjei O, Autenrieth IB, et al. (2000) Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 355: 1242-1243.
8. Hoerauf A, Specht S, Buttner M, Pfarr K, Mand S, et al. (2008) Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. MedMicrobiolImmunol 197: 295-311.
9. Mand S, Pfarr K, Sahoo PK, Satapathy AK, Specht S, et al. (2009) Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine. Am J Trop Med Hyg 81: 702-711.
10. Schwab AE, Boakye DA, Kyelem D, Prichard RK, (2005) Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment. Am J Trop Med Hyg 73: 234-238.
11. WHO (2011) WHO position statement on integrated vector management to control malaria and lymphatic filariasis. Wkly Epidemiol Rec 86: 121-127.
12. Bergquist R, Lustigman S, (2010) Control of important helminthic infections vaccine development as part of the solution. Advances in parasitology 73: 297-326.
13. Duke BO, (1993) The population dynamics of Onchocerca volvulus in the human host. Trop Med Parasitol 44: 61-68.
14. Bethony JM, Cole RN, Guo X, Kamhawi S, Lightowlers MW, et al. (2011) Vaccines to combat the neglected tropical diseases. Immunol Rev 239: 237-270.
15. Babayan SA, Attout T, Harris A, Taylor MD, Le Goff L, et al. (2006) Vaccination against filarial nematodes with irradiated larvae provides long-term protection against the third larval stage but not against subsequent life cycle stages. Int J Parasitol 36: 903-914.
16. Lange AM, Yutanawiboonchai W, Scott P, Abraham D, (1994) IL-4- and IL-5-dependent protective immunity to Onchocerca volvulus infective larvae in BALB/cBYJ mice. JImmunol 153: 205-211.
17. Dixit S, Gaur RL, Sahoo MK, Joseph SK, Murthy PS, et al. (2006) Protection against L3 induced Brugia malayi infection in Mastomys coucha pre-immunized with BmAFII fraction of the filarial adult worm. Vaccine 24: 5824-5831.
18. Makepeace BL, Jensen SA, Laney SJ, Nfon CK, Njongmeta LM, et al. (2009) Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure. PLoSNeglTropDis 3: e544.
19. Dabir S, Dabir P, Goswami K, Reddy MV, (2008) Prophylactic evaluation of recombinant extracellular superoxide dismutase of Brugia malayi in jird model. Vaccine 26: 3705-3710.
20. Rathaur S, Yadav M, Gupta S, Anandharaman V, Reddy MV, (2008) Filarial glutathione-S-transferase: a potential vaccine candidate against lymphatic filariasis. Vaccine 26: 4094-4100.
21. Vedi S, Dangi A, Hajela K, Misra-Bhattacharya S, (2008) Vaccination with 73kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models. Vaccine 26: 5997-6005.
22. Anand SB, Murugan V, Prabhu PR, Anandharaman V, Reddy MV, et al. (2008) Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice. Acta Trop 107: 106-112.
23. Wenk P, Wegerhof PH, (1982) Studies on acquired resistance of the cotton rat against microfilariae of Litomosoides carinii. 2. Injection of microfilariae during prepatency. ZParasitenkd 68: 321-329.
24. Haas B, Wenk P, (1981) Elimination of microfilariae (Litomosoides carinii Filarioidea) in the patent and in the immunized cotton-rat. TransRSocTropMedHyg 75: 143-144.
25. Kimmig P, Wenk P, (1982) [Suppression of parasitemia in rodent filariasis (Litomosoides carinii) by immunization with BCG and microfilaria. I. Intracutaneous inoculation of BCG]. ZParasitenkd 67: 317-327.
26. Petit G, Diagne M, Marechal P, Owen D, Taylor D, et al. (1992) Maturation of the filaria Litomosoides sigmodontis in BALB/c mice; comparative susceptibility of nine other inbred strains. Ann Parasitol Hum Comp 67: 144-150.
27. Chandrashekar R, Rao UR, Parab PB, Subrahmanyam D, (1986) Brugia malayi: rat cell interactions with infective larvae mediated by complement. Exp Parasitol 62: 362-369.
28. Al Qaoud KM, Taubert A, Zahner H, Fleischer B, Hoerauf A, (1997) Infection of BALB/c mice with the filarial nematode Litomosoides sigmodontis: role of CD4+ T cells in controlling larval development. InfectImmun 65: 2457-2461.
29. Hoffmann W, Petit G, Schulz-Key H, Taylor D, Bain O, et al. (2000) Litomosoides sigmodontis in mice: reappraisal of an old model for filarial research. ParasitolToday 16: 387-389.
30. Moreno Y, Nabhan JF, Solomon J, Mackenzie CD, Geary TG, (2010) Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi. Proc Natl Acad Sci U S A 107: 20120-20125.
31. Wolstenholme AJ, Rogers AT, (2005) Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelmintics. Parasitology 131 (Suppl): S85-95.
32. Goldstein B, (2001) On the evolution of early development in the Nematoda. Philosophical transactions of the Royal Society of London Series B, Biological sciences 356: 1521-1531.
33. Landmann F, Foster JM, Slatko B, Sullivan W, (2010) Asymmetric Wolbachia Segregation during Early Brugia malayi Embryogenesis Determines Its Distribution in Adult Host Tissues. PLoS Negl Trop Dis 4: e758.
34. Marechal P, Le Goff L, Hoffman W, Rapp J, Oswald IP, et al. (1997) Immune response to the filaria Litomosoides sigmodontis in susceptible and resistant mice. Parasite Immunol 19: 273-279.
35. Babayan S, Attout T, Specht S, Hoerauf A, Snounou G, et al. (2005) Increased early local immune responses and altered worm development in high-dose infections of mice susceptible to the filaria Litomosoides sigmodontis. MedMicrobiolImmunol 194: 151-162.
36. Specht S, Saeftel M, Arndt M, Endl E, Dubben B, et al. (2006) Lack of eosinophil peroxidase or major basic protein impairs defense against murine filarial infection. InfectImmun 74: 5236-5243.
37. Hotez P, (2011) Enlarging the "Audacious Goal": Elimination of the World's high prevalence neglected tropical diseases Vaccine Epub ahead of print.
38. Harris NL, Holloway J, Fitzharris P, McDonald M, Camberis M, et al. (2005) Tissue localization and frequency of antigen-specific effector CD4 T cells determines the development of allergic airway inflammation. Immunology and cell biology 83: 490-497.
39. Aebischer T, Morris L, Handman E, (1994) Intravenous injection of irradiated Leishmania major into susceptible BALB/c mice: immunization or protective tolerance. Int Immunol 6: 1535-1543.
40. Le Goff L, Martin C, Oswald IP, Vuong PN, Petit G, et al. (2000) Parasitology and immunology of mice vaccinated with irradiated Litomosoides sigmodontis larvae. Parasitology 120 (Pt 3): 271-280.
41. Moreno Y, Geary TG, (2008) Stage- and Gender-Specific Proteomic Analysis of Brugia malayi Excretory-Secretory Products. PLoSNeglTropDis 2: e326.
42. Sahoo MK, Sisodia BS, Dixit S, Joseph SK, Gaur RL, et al. (2009) Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection. Vaccine 27: 4263-4271.
43. Hoffmann WH, Pfaff AW, Schulz-Key H, Soboslay PT, (2001) Determinants for resistance and susceptibility to microfilaraemia in Litomosoides sigmodontis filariasis. Parasitology 122: 641-649.
44. Baxter D, (2007) Active and passive immunity, vaccine types, excipients and licensing. Occup Med (Lond) 57: 552-556.
45. Al Qaoud KM, Fleischer B, Hoerauf A, (1998) The Xid defect imparts susceptibility to experimental murine filariosis-association with a lack of antibody and IL-10 production by B cells in response to phosphorylcholine. IntImmunol 10: 17-25.
46. Gray CA, Lawrence RA, (2002) A role for antibody and Fc receptor in the clearance of Brugia malayi microfilariae. Eur J Immunol 32: 1114-1120.
47. Sahu BR, Mohapatra AD, Majumder A, Das PK, Ravindran B, (2005) A flow cytometry based method for studying embryogenesis and immune reactivity to embryogenic stages in filarial parasites. FilariaJ 4: 11.
48. Dunkelberger JR, Song WC, (2010) Complement and its role in innate and adaptive immune responses. Cell Res 20: 34-50.
49. Hoerauf A, Satoguina J, Saeftel M, Specht S, (2005) Immunomodulation by filarial nematodes. Parasite Immunol 27: 417-429.
50. Allen JE, Maizels RM, (2011) Diversity and dialogue in immunity to helminths. Nat Rev Immunol 11: 375-388.
51. Saeftel M, Volkmann L, Korten S, Brattig N, Al-Qaoud K, et al. (2001) Lack of interferon-gamma confers impaired neutrophil granulocyte function and imparts prolonged survival of adult filarial worms in murine filariasis. Microbes Infect 3: 203-213.
52. Taubert A, Zahner H, (2001) Cellular immune responses of filaria (Litomosoides sigmodontis) infected BALB/c mice detected on the level of cytokine transcription. Parasite Immunol 23: 453-462.
53. Lawrence RA, Allen JE, Osborne J, Maizels RM, (1994) Adult and microfilarial stages of the filarial parasite Brugia malayi stimulate contrasting cytokine and Ig isotype responses in BALB/c mice. J Immunol 153: 1216-1224.
54. Snapper CM, Paul WE, (1987) Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236: 944-947.
55. Mohr E, Cunningham AF, Toellner KM, Bobat S, Coughlan RE, et al. (2010) IFN- produced by CD8 T cells induces T-bet-dependent and-independent class switching in B cells in responses to alum-precipitated protein vaccine. Proc Natl Acad Sci U S A 107: 17292-17297.
56. Duthie MS, Windish HP, Fox CB, Reed SG, (2011) Use of defined TLR ligands as adjuvants within human vaccines. Immunol Rev 239: 178-196.
57. Turner JD, Langley RS, Johnston KL, Gentil K, Ford L, et al. (2009) Wolbachia lipoprotein stimulates innate and adaptive immunity through toll-like receptors 2 and 6 (TLR2/6) to induce disease manifestations of filariasis. JBiolChem 284: 22364-22378.
58. Martin C, Al-Qaoud KM, Ungeheuer MN, Paehle K, Vuong PN, et al. (2000) IL-5 is essential for vaccine-induced protection and for resolution of primary infection in murine filariasis. Med Microbiol Immunol 189: 67-74.
59. Volkmann L, Bain O, Saeftel M, Specht S, Fischer K, et al. (2003) Murine filariasis: interleukin 4 and interleukin 5 lead to containment of different worm developmental stages. Med Microbiol Immunol 192: 23-31.
60. Bockarie MJ, Taylor MJ, Gyapong JO, (2009) Current practices in the management of lymphatic filariasis. ExpertRevAntiInfectTher 7: 595-605.
61. Brindley PJ, Mitreva M, Ghedin E, Lustigman S, (2009) Helminth genomics: The implications for human health. PLoS neglected tropical diseases 3: e538.
62. Babayan SA, Allen JE, Taylor DW, (2011) Future prospects and challenges of vaccines against filariasis. Parasite immunology: Epub ahead of print.